1999
DOI: 10.1016/s0960-894x(99)00061-x
|View full text |Cite
|
Sign up to set email alerts
|

Studies towards the identification of potent, selective and bioavailable thrombin inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
9
0

Year Published

1999
1999
2004
2004

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 11 publications
0
9
0
Order By: Relevance
“…Although it has been described that the pH of the duodenum may vary within the range 5-7 [27][28][29], the most accurate range seems to be 6-6.5 [30][31][32][33][34]. Therefore, the pH of the digests was adjusted to 6.5 and the following were added (a) a bile salt mixture containing equimolar quantities (0.125 m) of sodium taurocholate (Sigma) and glycodeoxycholic acid (Calbiochem, La Jolla, CA, USA), …”
Section: In Vitro Duodenal Digestion (Phase 2)mentioning
confidence: 99%
See 1 more Smart Citation
“…Although it has been described that the pH of the duodenum may vary within the range 5-7 [27][28][29], the most accurate range seems to be 6-6.5 [30][31][32][33][34]. Therefore, the pH of the digests was adjusted to 6.5 and the following were added (a) a bile salt mixture containing equimolar quantities (0.125 m) of sodium taurocholate (Sigma) and glycodeoxycholic acid (Calbiochem, La Jolla, CA, USA), …”
Section: In Vitro Duodenal Digestion (Phase 2)mentioning
confidence: 99%
“…In vitro duodenal digestion was performed by using 120‐min gastric digests as the starting material. Although it has been described that the pH of the duodenum may vary within the range 5–7 [27–29], the most accurate range seems to be 6–6.5 [30–34]. Therefore, the pH of the digests was adjusted to 6.5 and the following were added (a) a bile salt mixture containing equimolar quantities (0.125 m ) of sodium taurocholate (Sigma) and glycodeoxycholic acid (Calbiochem, La Jolla, CA, USA), (b) 1 m CaCl 2 (BDH), (c) 0.25 m Bistris, pH 6.5 (Sigma), (d) porcine pancreatic lipase (EC 3.1.1.3; 20 µL per 10 mL of total volume) (0.1% w/v; Sigma product no.…”
Section: In Vitro Duodenal Digestion (Phase 2)mentioning
confidence: 99%
“…These problems seem to be circumvented to some degree by the recent report of a large number of weakly basic inhibitors, which do not contain the above-mentioned S1 anchoring group but incorporate isosters of these moieties, as well as other structural modifications that reduce the highly basic p K a of the parent inhibitors (in the range of 11−13) (). Among the most promising new S1 anchoring groups recently reported are the following moieties: oxoguanidine (A) (p K a 7) (); hydroxyguanidine (B) (p K a 9) (); acylguanidine (C) (p K a 7.6) (); aminohydrazone (D) (p K a 8.7) (); benzamidrazone (E) (p K a 8.9) (); sulfonylguanidine (F) (p K a 8.3) ( , ); sulfonylaminoguanidine (G) (p K a 8.4) ( , ); imidazole (H) (p K a around 7) (); 1-aminoisoquinoline (I) (p K a 7.5) (); 2-aminopyridine (J) (p K a around 7) (); benzylamine (K) (p K a 9.4) (); aniline (L) (p K a not provided but stated as “neutral”) ( , ); benzonitrile (M) (); and arylsulfonyldicyandiamide (N) (p K a of 7.9−8.2) () among others (Figure ). Compounds incorporating some of these groups, such as LB-30057 ( 1 ), CGH 1668 ( 2 ), L-375378 ( 3 ), or the Organon derivative 4 (Figure ), are currently under clinical investigation as antithrombotic drugs ( , ).…”
mentioning
confidence: 99%
“…Compounds incorporating some of these groups, such as LB-30057 ( 1 ), CGH 1668 ( 2 ), L-375378 ( 3 ), or the Organon derivative 4 (Figure ), are currently under clinical investigation as antithrombotic drugs ( , ).
1 Examples of S1 anchoring groups with reduced basicity incorporated in thrombin inhibitors: A, oxoguanidine (); B, hydroxyguanidine (); C, acylguanidine (); D, aminohydrazone (); E, benzamidrazone (); F, sulfonylguanidine ( , ); G, sulfonylaminoguanidine ( , ); H, imidazole (); I, 1-aminoisoquinoline (); J, 2-aminopyridine (); K, benzylamine (); L, aniline ( , ), M, benzonitrile (); N, arylsulfonyldicyandiamide ().
2 Examples of thrombin inhibitors: 1 , LB-30057; 2 , CGH 1668; 3 , L-375378; 4 , 2-(7-methoxynaphthalene-2-sulfonylamido)-3-(4-amino-5-azabenzothiophen-2-yl)propanoic acid 4-methylpiperidide; 5 , 4-[α-(4-toluenesulfonylureido)phenylalanylamido]benzenesulfonylguanidine; 6 , 4-[(2-ethyl-4,6-diphenylpyridinium)- N -propylcarboxamido]benzenesulfonyl- N -1-aminoguanidine; 7 , 4-aminobenzenesulfonylguanidine; 8 , 4-aminobenzenesulfonyl- N -1-aminoguanidine.
…”
mentioning
confidence: 99%
See 1 more Smart Citation